X-rays use low levels of radiation to make images of the inside of the body.
If you have a symptom or screening test that indicates cancer, the doctor will need to find out if it is due to cancer or to some other cause. Your doctor may start by asking about your personal and family medical history and taking a physical exam. The doctor can also order laboratory tests, imaging tests (scans) or other tests or procedures. You will also require a biopsy, which is sometimes referred to as a validated method to diagnose and classify cancer.
How cancer is generaly diagnosed
Biopsy
In most cases, clinicians need to do a biopsy to detect cancer. A biopsy is a process in which a sample of tissue is collected by the doctor. A pathologist looks at the tissue under a microscope and does several tests to see whether the tissue is cancer. The pathologist outlines the results in the pathology report, which details the diagnosis. Pathology findings play an important role in the diagnosis of cancer and in the decision-making of treatment choices.
Once you have a diagnosis of cancer
If the biopsy and other tests indicate that you have cancer, you will have further tests to help your doctor prepare your treatment. Your doctor would need to find out the stage of your cancer, for example.
For certain cancers, it is important to know the grade of the tumour or the risk category you are joining to decide on the best treatment. Your tumour can also be further examined for other tumours or genetic markers.
The Latest In Genomics Services and Technology
Clinical Whole Exome Sequencing (CLIA/CAP)
WES is one of the most comprehensive tools available for detecting rare diseases and associated variants in an individual’s DNA. Whole Exome includes all the protein coding regions in the human genome (approximately 20,000 genes), which is believed to cover > 85% of known and potential disease-causing genetic variants.
Who Benefits from WES?
- A genetically heterogeneous disorder
- A long list of differential diagnoses
- An atypical presentation of a genetic disorder
- A suspected genetic diagnosis, but previous genetic testing has been negative
- A need for a cost-effective alternative to whole genome sequencing
What we offer?
Offered in collaboration with “Novogene” is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world.
© 2024 Aceprobe. All rights reserved.